Mink Therapeutics, Inc.
INKT
Revenue
0.00
0.000.00%
-Assets
10.32M
▲3.43M▲49.75%
3 Months ChangeLiabilities
26.90M
▼-293.41k▼-1.08%
3 Months ChangeFree Cash Flow
-4.38M
▼-131.72k▼-3.10%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 8-K
ID: 0000950170-24-119270
2024-10-18
Form 8-K
ID: 0000950170-24-115596
2024-09-13
Form 8-K
ID: 0000950170-24-106345
2024-08-30
Form 8-K
ID: 0000950170-24-102321
2024-08-13
Form 10-Q
ID: 0000950170-24-096142
2024-08-13
Form 8-K
ID: 0001171843-24-004721
2024-06-17
Form 8-K
ID: 0000950170-24-074233
2024-05-16
Form 8-K
ID: 0000950170-24-060805
2024-05-14
Form 8-K
ID: 0001171843-24-002826
2024-05-14
Form 10-Q
ID: 0000950170-24-059081